Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Sandra Rayego Mateos"'
Autor:
Juan Guerrero-Mauvecin, Natalia Villar-Gómez, Sandra Rayego-Mateos, Adrian M. Ramos, Marta Ruiz-Ortega, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Acute kidney injury (AKI) frequently occurs in patients with chronic kidney disease (CKD) and in turn, may cause or accelerate CKD. Therapeutic options in AKI are limited and mostly relate to replacement of kidney function until the kidneys recover s
Externí odkaz:
https://doaj.org/article/4603271e47f0415885d835189067c5d3
Autor:
Vanessa Marchant, Flavia Trionfetti, Lucia Tejedor-Santamaria, Sandra Rayego-Mateos, Dante Rotili, Giulio Bontempi, Alessandro Domenici, Paolo Menè, Antonello Mai, Catalina Martín-Cleary, Alberto Ortiz, Adrian M. Ramos, Raffaele Strippoli, Marta Ruiz-Ortega
Publikováno v:
Antioxidants, Vol 12, Iss 12, p 2055 (2023)
Peritoneal dialysis (PD) is a current replacement therapy for end-stage kidney diseases (ESKDs). However, long-term exposure to PD fluids may lead to damage of the peritoneal membrane (PM) through mechanisms involving the activation of the inflammato
Externí odkaz:
https://doaj.org/article/dae14fbc054248da8adab7eae6dcecf9
Autor:
Sandra Rayego-Mateos, Laura Marquez-Exposito, Pamela Basantes, Lucia Tejedor-Santamaria, Ana B. Sanz, Tri Q. Nguyen, Roel Goldschmeding, Alberto Ortiz, Marta Ruiz-Ortega
Publikováno v:
Antioxidants, Vol 12, Iss 8, p 1541 (2023)
Inflammation is a key characteristic of both acute and chronic kidney diseases. Preclinical data suggest the involvement of the NLRP3/Inflammasome, receptor-interacting protein kinase-3 (RIPK3), and NRF2/oxidative pathways in the regulation of kidney
Externí odkaz:
https://doaj.org/article/5d896169b8334d5e895b9eea1e4e7c5b
Autor:
Raúl R. Rodrigues-Diez, Antonio Tejera-Muñoz, Macarena Orejudo, Laura Marquez-Exposito, Laura Santos, Sandra Rayego-Mateos, Elena Cantero-Navarro, Lucia Tejedor-Santamaria, Vanessa Marchant, Alberto Ortiz, Jesús Egido, Sergio Mezzano, Rafael Selgas, Juan F. Navarro-González, Jose M. Valdivielso, Carolina Lavoz, Marta Ruiz-Ortega
Publikováno v:
Nefrología, Vol 41, Iss 3, Pp 244-257 (2021)
Resumen: La interleuquina 17A (IL-17A) es una citoquina proinflamatoria producida por células del sistema inmune, sobre todo por los linfocitos Th17 y los linfocitos γδ. En este trabajo, revisamos el papel de IL-17A en la patogenia de la hipertens
Externí odkaz:
https://doaj.org/article/bc4b6400203c47e4a3f975601cac4a51
Autor:
Raúl R. Rodrigues-Diez, Antonio Tejera-Muñoz, Macarena Orejudo, Laura Marquez-Exposito, Laura Santos-Sanchez, Sandra Rayego-Mateos, Elena Cantero-Navarro, Lucia Tejedor-Santamaria, Vanessa Marchant, Alberto Ortiz, Jesús Egido, Sergio Mezzano, Rafael Selgas, Juan F. Navarro-González, Jose M. Valdivielso, Carolina Lavoz, Marta Ruiz-Ortega
Publikováno v:
Nefrología (English Edition), Vol 41, Iss 3, Pp 244-257 (2021)
Interleukin-17A (IL-17A) is a proinflammatory cytokine produced by cells of the immune system, predominantly Th17 and γδ lymphocytes. In this paper, we review the role of IL-17A in the pathogenesis of hypertension and in target organ damage. Precli
Externí odkaz:
https://doaj.org/article/83149afb48cd47049f3cfeb094a5b112
Autor:
Sandra Rayego-Mateos, Pamela Basantes, José Luis Morgado-Pascual, Beatriz Brazal Prieto, Beatriz Suarez-Alvarez, Alberto Ortiz, Carlos Lopez-Larrea, Marta Ruiz-Ortega
Publikováno v:
Antioxidants, Vol 12, Iss 5, p 1130 (2023)
Among the mechanisms involved in the progression of kidney disease, mitochondrial dysfunction has special relevance. Epigenetic drugs such as inhibitors of extra-terminal domain proteins (iBET) have shown beneficial effects in experimental kidney dis
Externí odkaz:
https://doaj.org/article/da9ed6c631bd4d0fb30bdba55b41da22
Autor:
Elena Cantero-Navarro, Sandra Rayego-Mateos, Macarena Orejudo, Lucía Tejedor-Santamaria, Antonio Tejera-Muñoz, Ana Belén Sanz, Laura Marquez-Exposito, Vanessa Marchant, Laura Santos-Sanchez, Jesús Egido, Alberto Ortiz, Teresa Bellon, Raúl R. Rodrigues-Diez, Marta Ruiz-Ortega
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Inflammation is a key characteristic of kidney disease, but this immune response is two-faced. In the acute phase of kidney injury, there is an activation of the immune cells to fight against the insult, contributing to kidney repair and regeneration
Externí odkaz:
https://doaj.org/article/eec648e0a92a47858d82fa4128d29513
Autor:
Laura Marquez-Exposito, Lucia Tejedor-Santamaria, Laura Santos-Sanchez, Floris A. Valentijn, Elena Cantero-Navarro, Sandra Rayego-Mateos, Raul R. Rodrigues-Diez, Antonio Tejera-Muñoz, Vanessa Marchant, Ana B. Sanz, Alberto Ortiz, Roel Goldschmeding, Marta Ruiz-Ortega
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Acute kidney injury (AKI) is more frequent in elderly patients. Mechanisms contributing to AKI (tubular cell death, inflammatory cell infiltration, impaired mitochondrial function, and prolonged cell-cycle arrest) have been linked to cellular senesce
Externí odkaz:
https://doaj.org/article/eb14e45a559945cd9ceb2ba0fcda3ed8
Autor:
Sandra Rayego-Mateos, Raul R Rodrigues-Diez, Beatriz Fernandez-Fernandez, Carmen Mora-Fernández, Vanessa Marchant, Javier Donate-Correa, Juan F. Navarro-González, Alberto Ortiz, Marta Ruiz-Ortega
Publikováno v:
Kidney International. 103:282-296
Diabetic kidney disease (DKD) is one of the fastest growing causes of chronic kidney disease and associated morbidity and mortality. Preclinical research has demonstrated the involvement of inflammation in its pathogenesis and in the progression of k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cbc72017fdfa3ca01385344cdbf1f7
https://doi.org/10.1016/j.kint.2022.10.030
https://doi.org/10.1016/j.kint.2022.10.030
Autor:
Sandra Rayego-Mateos, José Luis Morgado-Pascual, Carolina Lavoz, Raúl R. Rodrigues-Díez, Laura Márquez-Expósito, Antonio Tejera-Muñoz, Lucía Tejedor-Santamaría, Irene Rubio-Soto, Vanessa Marchant, Marta Ruiz-Ortega
Publikováno v:
Biomolecules, Vol 12, Iss 2, p 252 (2022)
Cellular communication network-2 (CCN2), also called connective tissue growth factor (CTGF), is considered a fibrotic biomarker and has been suggested as a potential therapeutic target for kidney pathologies. CCN2 is a matricellular protein with four
Externí odkaz:
https://doaj.org/article/46dc005de3084515b557898068a9a144